Open AccessExperience of use of human leukocyte interferon in remittent course of multiple sclerosis
Author(s) -
И. А. Завалишин,
В. Т. Khaidarov,
М. Н. Захарова,
Л. С. Адарчева,
А. S. Niyazbekova,
В П Кузнецов,
D. L. Belyaev,
А. А. Babayants
Publication year - 1997
Publication title -
nevrologičeskij vestnik
Language(s) - English
Resource type - Journals
eISSN - 2304-3067
pISSN - 1027-4898
DOI - 10.17816/nb79895
Subject(s) - multiple sclerosis , medicine , interferon , immunology , normalization (sociology) , anthropology , sociology
Results of follow up of 58 patients with remittent type of course of multiple sclerosis, who were treated with human leukocyte interferon for 3 years are presented. Improvement in the course of disease of incidence of aggravation and neurological deficite, normalization of cytokines allows to recommend human leucocyte interferon for treatment of multiple sclerosis.